Jane Carlton, PhD, director of the Johns Hopkins Malaria Research Institute at the Bloomberg School of Public Health and a Bloomberg Distinguished Professor, has been named a 2024 Honorary Fellow by the London School of Hygiene & Tropical Medicine. Carlton is a biologist and leader in the field of comparative genomics—the interdisciplinary study of an organism’s complete set of genes and DNA, or genome.
This prestigious Honorary Fellowship from LSHTM is given to individuals who have achieved exceptional international distinction in public health, international health, or tropical medicine. Carlton is being recognized for her outstanding contributions to the field of malaria research. The honor was conferred to Carlton at LSHTM’s graduation ceremony in London, on March 8.
As the Johns Hopkins Malaria Research Institute director, Carlton leads the Institute’s research that includes immunology and vaccine development, entomology, parasitology, and epidemiology, while developing genomics and systems biology approaches to the study of malaria. She also guides the Institute’s research training and public outreach focused on the threat malaria plays to global public health.
“I congratulate Jane on this impressive and well-deserved honor. Jane leads the Johns Hopkins Malaria Research Institute to identify new approaches to fight malaria - a serious public health problem and a challenging one to address scientifically,” says Arturo Casadevall, MD, PhD, Bloomberg Distinguished Professor and the Alfred and Jill Sommer Professor and Chair of the Bloomberg School’s Department of Molecular Microbiology and Immunology. The Institute resides within the Department at the Bloomberg School.
Carlton has published more than 165 research articles and reviews in journals including Nature and Science. She has been elected a fellow of the American Association for the Advancement of Science. Born and educated in Scotland, Carlton earned a PhD in Genetics from Edinburgh University in 1995.
The Johns Hopkins Malaria Research Institute, founded in 2001, conducts fundamental research at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, U.S.A, and field research at the Macha Research Trust in Zambia and other malaria endemic countries in Africa, southeast Asia and elsewhere. Globally, it is one of the most comprehensive research endeavors focused on malaria, advancing science to discover new drug targets, develop vaccines, and identify innovative strategies to prevent and control the disease.
